Q4 2022 Holdings
Filed 2023-02-14 | 61 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Prime Medicine, Inc.(PRME) | COM | 74168J101 | $246.8M | 13,284,688 | 14.3% |
| Verve Therapeutics Inc | COM | 92539P101 | $204.1M | 10,549,086 | 11.9% |
| UiPath Inc(PATH) | CL A | 90364P105 | $178.8M | 14,068,674 | 10.4% |
| Dexcom Inc(DXCM) | COM | 252131107 | $141.6M | 1,250,000 | 8.2% |
| Planet Labs PBC(PL) | COM CL A | 72703X106 | $139.0M | 31,942,641 | 8.1% |
| Eqrx Inc | COM | 26886C107 | $117.3M | 47,675,476 | 6.8% |
| Snowflake Inc(SNOW) | CL A | 833445109 | $76.9M | 535,604 | 4.5% |
| Crowdstrike Hldgs Inc(CRWD) | CL A | 22788C105 | $65.5M | 622,073 | 3.8% |
| Freshworks Inc(FRSH) | CLASS A COM | 358054104 | $59.4M | 4,035,595 | 3.4% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $59.1M | 24,042,864 | 3.4% |
| Gitlab Inc.(GTLB) | CLASS A COM | 37637K108 | $58.8M | 1,294,527 | 3.4% |
| Lyft Inc(LYFT) | CL A COM | 55087P104 | $57.9M | 5,257,563 | 3.4% |
| Duolingo Inc.(DUOL) | CL A COM | 26603R106 | $50.1M | 704,444 | 2.9% |
| Robinhood Mkts Inc(HOOD) | COM CL A | 770700102 | $40.1M | 4,928,535 | 2.3% |
| Benson Hill Inc. | COMMON STOCK | 082490103 | $39.7M | 15,352,271 | 2.3% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $23.4M | 1,568,753 | 1.4% |
| Lyell Immunopharma Inc. | COM | 55083R104 | $20.4M | 5,865,125 | 1.2% |
| Desktop Metal Inc. | COM CL A | 25058X105 | $15.0M | 11,048,730 | 0.9% |
| 23andMe Holding Co. | CLASS A COM | 90138Q108 | $14.6M | 6,736,785 | 0.8% |
| Beam Therapeutics Inc.(BEAM) | COM | 07373V105 | $12.6M | 321,604 | 0.7% |
| Monte Rosa Therapeutics Inc.(GLUE) | COM | 61225M102 | $11.1M | 1,464,015 | 0.6% |
| Sana Biotechnology Inc.(SANA) | COM | 799566104 | $11.1M | 2,812,500 | 0.6% |
| Illumina Inc.(ILMN) | COM | 452327109 | $10.8M | 53,470 | 0.6% |
| Rapt Therapeutics Inc.(RAPTEUR) | COM | 75382E109 | $10.7M | 540,270 | 0.6% |
| Invivyd Inc.(IVVD) | COM | 00534A102 | $8.5M | 5,680,785 | 0.5% |
| Vera Therapeutics Inc.(VERA) | CL A | 92337R101 | $5.8M | 301,580 | 0.3% |
| New Relic Inc.(NEWREUR) | COM | 64829B100 | $5.1M | 91,132 | 0.3% |
| Vaccitech PLC(BRNS) | ADS | 91864C107 | $3.6M | 1,513,644 | 0.2% |
| Decibel Therapeutics Inc. | COM | 24343R106 | $3.4M | 1,636,258 | 0.2% |
| Foghorn Therapeutics Inc.(FHTX) | COM | 344174107 | $3.2M | 500,901 | 0.2% |
| Rani Therapeutics Hldgs Inc.(RANI) | COM CL A | 753018100 | $3.0M | 510,128 | 0.2% |
| Kronos Bio Inc.(KRON1USD) | COM | 50107A104 | $2.3M | 1,438,232 | 0.1% |
| Amplitude Inc(AMPL) | COM CL A | 03213A104 | $2.3M | 189,447 | 0.1% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.9M | 255,452 | 0.1% |
| Tenaya Therapeutics Inc.(TNYA) | COM | 87990A106 | $1.8M | 915,705 | 0.1% |
| Evelo Biosciences Inc. | COM | 299734103 | $1.7M | 1,060,495 | 0.1% |
| Tscan Therapeutics Inc.(TCRX) | COM | 89854M101 | $1.6M | 1,077,080 | 0.1% |
| Alector Inc.(ALEC) | COM | 014442107 | $1.6M | 175,866 | 0.1% |
| Spero Therapeutics Inc.(SPRO) | COM | 84833T103 | $1.5M | 889,979 | 0.1% |
| Taysha Gene Therapies Inc.(TSHA) | COM SHS | 877619106 | $1.4M | 640,882 | 0.1% |
| Science 37 Holdings Inc. | COM | 808644108 | $1.3M | 3,207,260 | 0.1% |
| Magenta Therapeutics Inc. | COM | 55910K108 | $1.3M | 3,339,138 | 0.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADR | 05280R100 | $1.3M | 698,262 | 0.1% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $1.1M | 23,205 | 0.1% |
| Velo3d Inc | COMMON STOCK | 92259N104 | $1.0M | 572,400 | 0.1% |
| Hyperfine Inc.(HYPR) | COM CL A | 44916K106 | $754.9K | 898,720 | 0.0% |
| Oportun Finl Corp(OPRT) | COM | 68376D104 | $522.3K | 94,788 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $401.7K | 215,965 | 0.0% |
| Quince Therapeutics Inc(QNCX) | COM | 22053A107 | $121.0K | 189,122 | 0.0% |
| Repligen Corp(RGEN) | COM | 759916109 | $64.8K | 383 | 0.0% |